Sign Up Today and Learn More About Genespire Stock
Invest in or calculate the value of your shares in Genespire or other pre-IPO companies through EquityZen's platform.
Genespire Stock
Genespire is a biotechnology company focused on the development of transformative gene therapies for patients affected by genetic diseases.
About Genespire Stock
Founded
2020
Industries
Software, Artificial Intelligence, Data and Analytics
Genespire Press Mentions
Stay in the know about the latest news on Genespire
Preclinical insights into dosing for first-in-human in vivo liver-directed gene therapy for MMA delivered in an oral presentation at the ASGCT Annual Meeting
biospace • May 17, 2025
Preclinical insights into dosing for first-in-human in vivo liver-directed gene therapy for MMA delivered in an oral presentation at the ASGCT Annual Meeting
globenewswire • May 17, 2025
Preclinical insights into dosing for first-in-human in vivo liver-directed gene therapy for MMA delivered in an oral presentation at the ASGCT Annual Meeting
globenewswire • May 17, 2025
Genespire announces oral presentation at the ASGCT Annual Meeting detailing preclinical insights into dosing for first-in-human in vivo liver-directed ISLV gene therapy for MMA
globenewswire • May 08, 2025
Lentiviral vector
patents • Apr 02, 2025
Genespire Management
Leadership team at Genespire
CEO
Karen Pignet-Aiach
Board Member
Graziano Seghezzi
Join now and verify your accreditation status to gain access to:
- Genespire Current Valuation
- Genespire Stock Price
- Genespire Management
- Available deals in Genespire and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Genespire Cap Table and Funding History by Share Class and Liquidity Preferences
- Genespire Revenue and Financials
- Genespire Highlights
- Genespire Business Model
- Genespire Risk Factors
- Genespire Research Report from SACRA Research
Trading Genespire Stock
How to invest in Genespire stock?
Accredited investors can buy pre-IPO stock in companies like Genespire through EquityZen funds. These investments are made available by existing Genespire shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Genespire stock?
Shareholders can sell their Genespire stock through EquityZen's private company marketplace. EquityZen's network includes over 370K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
